L&C Bio Co., Ltd (290650.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap1.5T
Enterprise Value1.57T
P/E Ratio-9.73
PEG Ratio0.05
Price/Sales Ratio15.66
Price/Book Ratio4.98
Enterprise/Revenue15.9
Enterprise/EBITDA107.58

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-1.29
Operating Margin0.17
AD

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.61

Income Statement

Revenue85.48B
Revenue/Share4,312.36
Gross Profit41.32B
EBITDA11.57B
Net Income-138.17B
Diluted EPS-5,811.4

Balance Sheet

Total Cash41.53B
Total Cash/Share1,540.02
Total Debt63.77B
Total Debt/Equity0.2
Current Ratio1.33
Book Value Per Share12,428.35

Price History

52-Week Change17.42
52-Week High125,000
52-Week Low42,150
Moving Average 50 Days52,628.07
Moving Average 200 Days68,635.27

Statistics

Average Volume283,685
Shares Outstanding30.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate50
Trailing Annual Dividend Yield0.08
Payout Ratio-0.01
Last Split Factor2:1
Last Split DateOctober 26, 2026
AD